Main Menu

Oyster Point Pharma, Inc.

(NASDAQ GS: OYST)

Rigrodsky Law, P.A. is investigating Oyster Point Pharma, Inc. (“Oyster”) regarding possible breaches of fiduciary duties and other violations of law related to Oyster’s agreement to be acquired by Viatris Inc.  Under the terms of the agreement, Oyster’s shareholders will receive $11.00 per share and a contingent value right for a potential cash payment of up to $2.00 per share.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 11/21/2022


* Indicates a required field.

Back to Page